• HOME
  • RESEARCH
  • PEOPLE
  • PUBLICATIONS
  • SUPPORT US
  • NEWS
  • CONTACT
Mancias Lab - Pancreatic Cancer Research

Mancias Laboratory
PANCREATIC CANCER RESEARCH

New Vevo 3100 Pre-clinical Ultrasound arrives

4/12/2018

0 Comments

 
Picture
With support from a number of Dana-Farber Cancer Institute Labs, the Hale Family Research Center, and with a grant to the Mancias Lab from the Friends of DFCI, a new Vevo 3100 Pre-clinical Ultrasound is now available for use for pre-clinical studies in pancreatic cancer (and other cancers). The Vevo 3100 ultrasound offers unparalleled ability to identify, measure, and track mouse pancreatic tumors during the course of genetic or pharmacologic experiments. This technology will prove invaluable for our studies with the ultimate goal of translating new therapies to patients diagnosed with pancreatic cancer. For more information on the Vevo 3100 ultrasound, click here.
0 Comments



Leave a Reply.

    Archives

    September 2020
    July 2020
    June 2020
    March 2020
    February 2020
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    June 2018
    May 2018
    April 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    May 2017
    April 2017
    March 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    May 2016
    March 2016
    February 2016
    October 2015
    June 2015
    May 2015
    October 2014
    May 2014
    March 2014
    July 2013

    Categories

    All

    RSS Feed

 HOME | RESEARCH | PEOPLE | PUBLICATIONS | SUPPORT US | NEWS | CONTACT

©2017 Mancias Lab at Dana-Farber Cancer Institute